← Every company
Halozyme Therapeutics Inc SEC Filings
What Halozyme Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
HALO overview →Filings on file
143
since Nov 7, 2016
Warning signs
2
latest Nov 12, 2019
Last results
Aug 6, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
Source: Halozyme Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on HALO
Company overviewEverything on HALO in one place, with the price.Insider tradingWhat HALO's own officers and directors buy and sell.Planned salesSales HALO insiders have filed notice of.Who owns itEvery manager reporting a position in HALO.Funds holding itWhich funds and ETFs hold HALO, and how big a bet.LobbyingWhat HALO spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on HALO's account, and who they worked for.PatentsWhat HALO is filing at the patent office.